BRAVA,CONCERTO II, MAXIMO II PRTECTA CRT-D,CONCERTO CONSULTA,INSYNC II PROTECT, INSYNC III MARQUIS , INSYNC MAXIMOICD
FDA premarket approval P010031/S438 · decided 2014-05-23
Approval details
- PMA number
- P010031
- Supplement
- S438
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- BRAVA,CONCERTO II, MAXIMO II PRTECTA CRT-D,CONCERTO CONSULTA,INSYNC II PROTECT, INSYNC III MARQUIS , INSYNC MAXIMOICD
- Generic name
- Pulse generator, permanent, implantable
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2014-03-28
- Decision date
- 2014-05-23
- Days to decision
- 56 days
- Decision code
- APPR
- Product code
- NVZ
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- APPROVAL FOR FIRMWARE UPDATES TO THE MYCARELINK PATIENT MONITOR24950.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.